ELDRED KARY 4
4 · GALECTIN THERAPEUTICS INC · Filed Jan 13, 2020
Insider Transaction Report
Form 4
ELDRED KARY
Director
Transactions
- Award
Stock option (right to buy)
2020-01-09+30,000→ 30,000 totalExercise: $2.86Exp: 2030-01-09→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest 100% on December 31, 2020.